Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
A phase 3 trial of Ethiodized oil in Hepatocellular carcinoma, run by Stanford University, recorded as terminated on the registry.
Overview
Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization is a phase 3 interventional study registered as NCT02762266 by Stanford University, with 13 participants recorded, started 2016-02-27 and due to reach its primary completion in 2022-12-31. Interventions recorded: Stereotactic Body Radiation Therapy, Transarterial Chemoembolization, embolic agent, lipiodol. Conditions recorded: Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma.
Linked to the drug Ethiodized oil because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialLiver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
Shares Ethiodized oil, Hepatocellular carcinoma and the tag pipeline.
- TrialEndovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
Shares Ethiodized oil, Hepatocellular carcinoma and the tag pipeline.
- TrialEfficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialOri-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialA Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialThermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialNWRD06 DNA Plasmid for HCC After Curative Resection.
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialTo Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization
Shares Hepatocellular carcinoma and the tag pipeline.